Pacira Pharmaceuticals reported $21.31M in EBIT for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Adamas Pharmaceuticals ADMS:US -14977000 6.21M
Aerie Pharmaceuticals AERI:US $ -34219000 1.37M
Amerisourcebergen ABC:US $ 702.5M 84.89M
Antares Pharma ATRS:US $ 5.39M 707K
Astellas Pharma 4503:JP -24163000000 96.76B
Biodelivery Sciences International BDSI:US $ 7.44M 5.08M
Bristol Myers Squibb BMY:US $ 2556M 1406M
Cara Therapeutics CARA:US $ 78.29M 95.31M
Endo International Ordinary Shares ENDP:US $ 219.43M 43.78M
Horizon Pharma HZNP:US -89446000 326.97M
JAZZ PHA JAZZ:US 162.12M 11.3M
Johnson & Johnson JNJ:US $ 7580.4M 3038.4M
Lannett LCI:US $ 2.85M 21.45M
Ligand Pharmaceuticals LGND:US $ 5.14M 11.04M
Nektar Therapeutics NKTR:US $ -109392000 1.33M
Pacira Pharmaceuticals PCRX:US $ 21.31M 4.24M
Pfizer PFE:US $ 5757M 4605M
Revance Therapeutics RVNC:US $ -77969000 841K
Supernus Pharmaceuticals SUPN:US $ 13.21M 29.88M
Teva Pharmaceutical TEVA:IT 794M 12M
Xoma XOMA:US $ -6427000 30.3M
Zoetis ZTS:US $ 759M 243M